Here, we have further explored the interaction between XA and mGlu2/3 receptors using in vitro and in vivo models, and we assessed serum levels of XA and other kynurenines in a large cohort of patients affected by schizophrenia, their first-degree relatives, and healthy controls. Here, GRM2 is linked to schizophrenia.